The chronic phase
Rules applying to both the acute phase and the chronic phase of pain treatment
5
EVALUATION OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AS THE CHRONIC PHASE OF DISEASE USING MACHINE LEARNING TECHNIQUES
12
Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis
18
Monitoring Of Bcr-abl Levels In Chronic Myeloid Leukemia Patients Treated With Imatinib In The Chronic Phase - The Importance Of A Major Molecular Response
5
Bilateral Arm Training in the Chronic Phase of Stroke Rehabilitation: A Systematic Review and Meta-analysis
9
Probing Population Dynamics of Trypanosoma cruzi during Progression of the Chronic Phase in Chagasic Patients
8
COMPREHENSIVE REHABILITATION PROGRAMMES IN THE CHRONIC PHASE AFTER SEVERE BRAIN INJURY: A SYSTEMATIC REVIEW
14
Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection
10
WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
10
Chronic Myeloid Leukaemia in Advanced Phase: An Analytical Evaluation
5
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
11
Acute compartment syndrome as the initial manifestation of chronic phase chronic myeloid leukemia: a case report and review of the literature
6
Molecular and Serological Techniques to Determine the Acute and Chronic Phase of Toxoplasmosis in HIV Patients
7
Phase distribution of chronic myeloid leukemia in Bangladesh
7
Management of Chronic Myeloid Leukemia in Advanced Phase
18
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
6
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
9
A Case of Isolated CNS Relapse in a CML Patient on Chronic Phase
8
Acute versus chronic phase mechanisms in a rat model of CRPS
15
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
10